메뉴 건너뛰기
Ophthalmology
Volumn 120, Issue 9, 2013, Pages
Ranibizumab in myopic choroidal neovascularization: The 12-month results from the repair study

(17)  Tufail, Adnan a   Narendran, Nirodhini b   Patel, Praveen J a   Sivaprasad, Sobha a   Amoaku, Winfried c   Browning, Andrew C d   Osoba, Olayinka e   Gale, Richard f   George, Sheena g   Lotery, Andrew J h   Majid, Mohammed i   McKibbin, Martin j   Menon, Geeta k   Andrews, Christopher l   Brittain, Christopher l   Osborne, Aaron l   Yang, Yit b  

Author keywords

[No Author keywords available]
Indexed keywords

RANIBIZUMAB;
EID: 84883746108     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2013.06.010     Document Type: Letter
Times cited : (97)
References (5)
  • 1
    • 85044558392 scopus 로고    scopus 로고
    • Ranibizumab for the treatment of choroidal neovascularisation secondary to pathological myopia: Interim analysis of the REPAIR study
    • A. Tufail, P.J. Patel, and S. Sivaprasad Ranibizumab for the treatment of choroidal neovascularisation secondary to pathological myopia: interim analysis of the REPAIR study Eye (Lond) 27 2013 1 7
    • (2013) Eye (Lond) , vol.27 , pp. 1-7
    • Tufail, A.1    Patel, P.J.2    Sivaprasad, S.3
  • 2
    • 84863876595 scopus 로고    scopus 로고
    • Long-term outcome of intravitreal anti-vascular endothelial growth factor therapy with bevacizumab or ranibizumab as primary treatment for subfoveal myopic choroidal neovascularization
    • T.Y. Lai, F.O. Luk, G.K. Lee, and D.S. Lam Long-term outcome of intravitreal anti-vascular endothelial growth factor therapy with bevacizumab or ranibizumab as primary treatment for subfoveal myopic choroidal neovascularization Eye (Lond) 26 2012 1004 1011
    • (2012) Eye (Lond) , vol.26 , pp. 1004-1011
    • Lai, T.Y.1    Luk, F.O.2    Lee, G.K.3    Lam, D.S.4
  • 3
    • 84859378676 scopus 로고    scopus 로고
    • The 12-month outcome of three consecutive monthly intravitreal injections of ranibizumab for myopic choroidal neovascularization
    • T.T. Wu, and Y.H. Kung The 12-month outcome of three consecutive monthly intravitreal injections of ranibizumab for myopic choroidal neovascularization J Ocul Pharmacol Ther 28 2012 129 133
    • (2012) J Ocul Pharmacol Ther , vol.28 , pp. 129-133
    • Wu, T.T.1    Kung, Y.H.2
  • 4
    • 84155170752 scopus 로고    scopus 로고
    • Long-term follow-up of myopic choroidal neovascularization treated with ranibizumab
    • N. Franqueira, M.L. Cachulo, and I. Pires Long-term follow-up of myopic choroidal neovascularization treated with ranibizumab Ophthalmologica 227 2012 39 44
    • (2012) Ophthalmologica , vol.227 , pp. 39-44
    • Franqueira, N.1    Cachulo, M.L.2    Pires, I.3
  • 5
    • 77953595489 scopus 로고    scopus 로고
    • Interobserver agreement for the detection of optical coherence tomography features of neovascular age-related macular degeneration
    • P.J. Patel, A.C. Browning, and F.K. Chen Interobserver agreement for the detection of optical coherence tomography features of neovascular age-related macular degeneration Invest Ophthalmol Vis Sci 50 2009 5405 5410
    • (2009) Invest Ophthalmol Vis Sci , vol.50 , pp. 5405-5410
    • Patel, P.J.1    Browning, A.C.2    Chen, F.K.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.